Drug companies deserve more patent protection, judge says

05/16/2010 | National Law Journal (free registration), The

Pharmaceutical companies should be given extended patent protection to compensate for the lengthy drug-approval pipeline, according to a ruling by the U.S. Court of Appeals for the Federal Circuit. The court ruled that the Patent and Trademark Office had incorrectly denied a patent-extension request pertaining to a cancer treatment.

View Full Article in:

National Law Journal (free registration), The

Published in Brief:

SmartBrief Job Listings for Business

Job Title Company Location
Vice President, HEDIS & Performance Outcomes
Dayton, OH